Trial Profile

A phase 3, open-label trial to evaluate the safety, tolerability, and immunogenicity of a 13vPnC when administered to healthy Japanese adults aged greater than or equal to 65 years and 50 to 64 years in Japan who have not received a previous dose of 23-valent pneumococcal polysaccharide vaccine

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 19 Nov 2011

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

12 Aug 2008 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
12 Aug 2008 Actual number of patients is 270 as reported by ClinicalTrials.gov.
29 Apr 2008 Status changed from recruiting to in prgoress.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com